Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery

Liver

Volumn 16, Issue 2, 1996, Pages 110-116

  Bart, P A ^a   Jacquier, P ^b   Zuber, P L F ^c   Lavanchy, D ^a   Frei, P C ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

HBV and HDV infection; Isolated anti HBc; Seroprevalence; Women at delivery

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; DELIVERY; DELTA AGENT HEPATITIS; FEMALE; HEPATITIS B; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SWITZERLAND; UMBILICAL CORD BLOOD;

EID: 0030005111     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00714.x     Document Type: Article

References (38)

1. KANE M A. Progress on the control of hepatitis B infection through immunisation. Gut 1993: Suppl: S10-S12.
2. PERRILLO R P. Hepatitis B: transmission and natural history. Gut 1993: Suppl. S48-S49.
3. NDUMBE P M, ANDELA A, NKEMNKENG-ASONG J, WATONSI E, NYAMBI P. Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon. Med Microbiol Immunol 1992: 181: 127-130.
4. WANG L Y, CHENG Y W, CHOU S J, HSIEH L L, CHEN C J. Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey. J Med Virol 1993: 39: 1-5.
5. PURO V, GIRARDI E, IPPOLITO G, et al. Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecot 1992: 99: 598-600
6. STROFFOLINI T, CHIARAMONTE M, CRAXI A, et al. Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination. J Infect 1991: 22: 191-199.
7. BORTOLOTTI F, CADROBBI P, CRIVELLARO C, et al. The changing epidemiology of acute type B hepatitis: results of an 11-year prospective study in Padua (Northern Italy). Infection 1989: 17: 364-368.
8. DAL-RÉ R, AGUILAR L, CORONEL P. Current prevalence of hepatitis B, A and C in a healthy Spanish population. A seroepidemiological study. Infection 1991: 19: 409-413.
9. BOGOMOLSKI-YAHALOM V, GRANOT E, LINDER N, et al. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. J Med Virol 1991: 34: 217-222.
10. HYAMS K C, OSMAN N M, KHALED E M, et al. Maternal-infant transmission of hepatitis B in Egypt. J Med Virol 1988: 24: 191-197.
11. ALTER M J, HADLER S C, MARGOLIS H S, et al. The changing epidemiology of hepatitis B in the United States. JAMA 1990: 263: 1218-1222.
12. COZEN W, MASCOLA L, ENGUIDANOS R, et al. Screening for HIV and hepatitis B virus in Los Angeles County prenatal clinics: a demonstration project. J Acquir Immune Defic Syndr 1993: 6: 95-98.
13. STRUVE J. Hepatitis B virus infection among Swedish adults: aspects on seroepidemiology, transmission, and vaccine response. Scand J Infect Dis 1992: Suppl 82: 1-57.
14. STRUVE J, KÄLL K, STENDAHL P, SCALIA-TOMBA G, GIESECKE J, WEILAND O. Prevalence of hepatitis B virus markers among intravenous drug abusers in Stockholm: impact of heterosexual transmission. Scand J Infect Dis 1993: 25: 8-13.
15. HART G J, DAWSON J, FITZPATRICK R M, et al. Risk behaviour, anti-HIV and anti-HBc prevalence in clinic and nonclinic samples of gay men in England. 1991-1992. AIDS 1993: 7: 863-869.
16. KVINESDAL B B, WORM A M, GOTTSCHAU A. Risk factors for hepatitis B virus infection in heterosexuals attending a venereal disease clinic in Copenhaaen. Scand J Infect Dis 1993: 25: 171-175.
17. SOULIÉ J C, LARSEN M, GOUDEAU A, et al. Transmission périnatale du virus de l'hépatite B dans la région de Paris. Ann Pédiatr (Paris) 1991: 38: 595-601.
18. ROUDOT-THORAVAL F, KOUADJA F, WIRQUIN V, et al. Prévalence du portage de l'antigène HBs et des marqueurs de replication virale B dans une population de femmes enceintes, en France. Gastroenterol Clin Biol 1989: 13: 353-356.
19. SALUEN J P. Anticorps anti-HBc chez les donneurs de sang. Répartition par sexes et classes d'âge. Rev Fr Transfus Hémobiol 1991: 34: 369-373.
20. BAUMANN H, SCHNEIDER H, GROB P J, HUGH R, HUCH A. Häufigkeit des HBsAg bei symptomfreien schwangeren Frauen. Resultate eines Screening an der Universitätsfrauenklinik Zürich. Schweiz Med Wochenschr 1984: 114: 783-787.
21. RÖHRIG S, GROB P J. Infektionen mit den Hepatitisviren HAV. HBV, und HCV sowie mit dem Aidsvirus HIV bei Drogenabhängigen der Gassenszene Zürichs - eine Prävalenzstudie. Schweiz Med Wochenschr 1990: 120: 621-629.
22. KÄGI M K, JOLLER H, WUNDERLI W, RÜDLINGER R, JOLLER- JEMELKA H I. Prävalenz von Cytomegalievirus, Hepatitis-B- und HIV-1-Antikörpern bei gesunden Blutspendern, Spitalpatienten, Patienten vor Nierentransplantation, i.v.-Drogenabhängigen und Homosexuellen. Schweiz Med Wochenschr 1989: 119: 217-222.
23. PALMER BEASLEY R, HWANG L Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983: 147: 185-190.
24. TONG M J, THURSBY M, RAKELA J, MCPEAK C, EDWARDS V M, MOSLEY J W. Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroemerology 1981: 80: 999-1004.
25. HOOFNAGLE J H, SEEFF L B, BUSKELL BALLES Z, ZIMMERMAN H J, THE VETERANS ADMINISTRATION HEPATITIS COOPERATIVE STUDY GROUP. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978: 298: 1379-1383.
26. DIKE A E. Post-transfusion hepatitis B transmitted by HBsAg negative blood containing anti-HBc. Med Lab Sci 1981: 38: 415-417.
27. OFFFCE FÉDÉRAL DE LA STATISTIQUE, SWITZERLAND. Annuaire statistique de la Suisse, Zürich: Verlag Neue Zürcher Zeitung, 1992.
28. ZUBER P L F, JACQUIER P, HOHLFELD P, WALKER A M. Toxoplasma infection among pregnant women in Switzerland: a cross-sectional evaluation of regional and age-specific life-time average annual incidence. Am J Epidemiol: in press.
29. JACQUIER P, HOHLFELD P, VORKAUF H, ZUBER P. Epidémiologie de la toxoplasmose in Suisse; étude nationale de séroprévalence menée chez les femmes enceintes en 1990-1991. J Suisse Méd: in press.
30. KANEKO S, FEINSTONE S M, MILLER R H. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. K Clin Microbiol 1989: 27: 1930-1933.
31. TIOLLAIS P, CHARNAY P, VYAS G N. Biology of hepatitis B virus. Science 1981: 213: 406-411.
32. GUO K J, BOWDEN D S. Digoxigenin-labeled probes for the detection of hepatitis B virus DNA in serum. J din Microbiol 1991: 29: 506-509.
33. LOK A S F, LAI C L, WU P C. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988: 8: 766-770.
34. BRÉCHOT C, DEGOS F, LUGASSY C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985: 312: 270-276.
35. SÁNCHEZ-QUIJANO A, JAUREGUI J I, LEAL M, et al. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 1993: 17: 288-293.
36. WANG J T, WANG T H, SHEU J C, SHIH L N, LIN J T, CHEN D S Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991: 163: 397-399.
37. LUO K X, ZHOU R, HE C, LIANG Z S, JIANG S. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991: 35: 55-59.
38. STROUN J, PEITREQUIN R, FREI P C. Etude sérologique rétrospective (1970-1984) de l'antigène et de l'anticorps delta. Schweiz Med Wochenschr 1987: 117: 307-314.